box warning invokana

You had 2 trials that showed 2x amount of leg amps not just 1 trial. The drug should be pulled. Do the others in the class show this 2x in their long-term trials? No. If your docs think it's a class effect it's because they are ignorant. When the find out will they be a-okay then?

 

Saw a commercial on T.V. today warning patients taking invokana of an increased risk of amputation and ketoacidosi. Sponsored by the Goldwater law firm along with a toll-free number. This will make doctors stay away from invokana like it's radioactive.

 

Saw a commercial on T.V. today warning patients taking invokana of an increased risk of amputation and ketoacidosi. Sponsored by the Goldwater law firm along with a toll-free number. This will make doctors stay away from invokana like it's radioactive.

 

Thanks captain obvious.Thats a year old!!

 

NO THEY DON'T!!! Learn the real story before you go out and make us all look bad. Oh and do you think saying its a class effect helps the class? Duhhhhhhh the DPP4 rep is having a field day. Nice way to ruin the class as a whole.....SMH

 

ok Janssen whiners - you still have a job and the Contract Reps don't. You will face label changes and more with Invokana now after the thud of CANVAS and amputation box warning headed your way. So suck it up, do your job, enjoy your perks or look elsewhere! After 20+ years at Big Pharma I survived that layoff and this CSO layoff. You will never find another job that pays you to do this job. Reflect and go sell. You have 2 great drugs, you will get thru this Invo mess. Good luck, good selling kids!
Signed, the CSO you thought was taking your job, lol

 

Just a matter of time before IK gets pulled. Read the writing on the wall. J&J displaced their CSO specialists, next will be primary care, then reduction in their own company salesforce. You all should be looking to get out before you are booted out.

 

Fear talk; it will not be pulled. Stock is $136 an all-time high.

 

Go away troll. You obviously do not know who was displaced. Keep spreading your fake news to Doc's about our CV trial. They see right through you lies and fabrications.
BTW, keep up the great selling messages. They love hearing you bring it up over and over and over again!

 

One thing about being a Janssen rep is that you are always putting out a fire.

 

I'm so happy Janseen discrimates against people in interviews after seeing this study drop. Dodged that bullet! Enjoy the diversity in the unemployment lines!!!!

 

i kerp trying to hit that we are the same but I worry when the read I'll have egg on my face. Just my thoughts.

 

National NBRX down again. The future not so bright. What do you think? Reductions first of year? 1 person territories for retail?

 

Farxiga reps need to very careful in continuing to emphasize INV the safety update, especially when their drug was delayed by the FDA for approval due to increased risk of bladder cancer 5x greater than placebo. Doctors are seeing through their sleepy sales tactics and it is having an opposite effect.

 

Get rid of overhead and unnecessary. Bigger territories are a better solution; no over coverage. Quality is necessary not quantity. DMS could have more people under them in some cases. There are always ways to SAVE and that is the name of the game today.

 

Do you really want to market Invokana as the lesser of two evils?

 

In some cases?! You could eliminate every DM in Janssen PC and it wouldn't do a thing except save shareholders money. The smart move would be to eliminate half of the reps and all of the DMs. From there, spread who remains into single-person territories, and put the top 10% of reps as overlays across the entire district, acting as the second rep calling on the top 10% of prescribers across the district. That rep would also ride with and coach the other district reps 2 days/week. Administrative support could be provided by one coordinator per region, with RBDs handling personnel issues. Assuming there are currently an average of 8 reps per district, averaging $250k/yr (fully loaded cost with car, retirement, health, travel, and other expenses) and DMs averaging $300k/yr that would save the company almost $150 million a year and I would be willing to bet it wouldn't make a bit of difference in top line sales.

Until very recently this company had the two best products in the market in their respective classes and was still being out sold and out marketed. This tells me that the weak link at Janssen is the people, so get rid of them! Janssen has been a great exporter of talent for years, why not export some of the dead weight too. Hopefully someone there will realize this and soon, so you can stop wasting money on yes-men who haven't had an original thought since Janssen was Ortho, and start investing it in the people who will challenge the way things are done and bring Janssen back onto the right course.